Sentences with phrase «aids vaccine trial»

It is also acknowledges the vital contributions of approximately 20,000 volunteers enrolled in AIDS vaccine trials around the world today who have selflessly committed to advancing research.

Not exact matches

Researchers at Oregon Health & Science University are currently looking for volunteers that can be tested during an upcoming clinical trial for a vaccine that may cure HIV, the virus that causes AIDS.

The long search for an AIDS vaccine has produced countless false starts and repeated failed trials, casting once bright hopes into shadows of disenchantment.

But rather than dashing all hopes for an AIDS vaccine, the trial has heartened some researchers, who see new clues in the battle against the fatal illness.

Costing $ 105 million and enrolling more than 16,000 subjects, the Thai clinical trial was the largest AIDS vaccine test to date.

In 1991 the WHO decided to support Uganda, Rwanda, Thailand and Brazil in preparing for the first field trials of AIDS vaccines, but of these only Thailand is close to starting a trial.

China is to be the first non-Western country to conduct a trial of an experimental AIDS vaccine.

The results came as a surprise to HIV - vaccine skeptics in the AIDS (acquired immunodeficiency syndrome) research field, whose numbers have increased after years of failed vaccine trials.

To address that debate, Kojic's study, dubbed «AIDS Clinical Trials Group Protocol 5240,» measured the safety and immune system response of the vaccine in HIV - positive women aged 13 to 45 with a wide range of immune statuses.

Of more than 50 therapeutic vaccine trials so far, this is the first one that has bolstered the immune system in a «meaningful» way, says Steven Deeks, an HIV / AIDS clinician and researcher at the University of California, San Francisco, who is «cautiously optimistic» that the data will inspire others to study the approach.

Without any prospect of trials, the AIDS vaccine industry would die.

The row over the Thai trials has been fuelled by an explosive mix of factors, including the pace at which the HIV epidemic is growing in Asia, the future of the vaccines industry, and domestic tensions in the US between AIDS researchers, activists and politicians.

The army landed $ 20 million for a trial of an AIDS vaccine after heavy lobbying, in part from the company that makes the vaccine.

The HIV Vaccine Trials Network (HVTN) is the largest worldwide clinical trials network dedicated to the development and testing of HIV / AIDS vacTrials Network (HVTN) is the largest worldwide clinical trials network dedicated to the development and testing of HIV / AIDS vactrials network dedicated to the development and testing of HIV / AIDS vaccines.

«The two greatest challenges remaining in HIV / AIDS research are finding a cure and developing a safe and effective preventive vaccine,» said Anthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases, which is leading the vaccine trial.

In the new issue of IAVI Report we wrote about how researchers at the AIDS Vaccine 2010 conference in Atlanta discussed the limited window of opportunity for conducting clinical trials to test partially effective HIV prevention strategies, including HIV vaccine candidates and oral or topical antiretroviral pre-exposure prophylaxis (PrEP), in combiVaccine 2010 conference in Atlanta discussed the limited window of opportunity for conducting clinical trials to test partially effective HIV prevention strategies, including HIV vaccine candidates and oral or topical antiretroviral pre-exposure prophylaxis (PrEP), in combivaccine candidates and oral or topical antiretroviral pre-exposure prophylaxis (PrEP), in combination.

The trials will be conducted by the publicly funded, Hutch - based HIV Vaccine Trials Network, or HVTN, the largest global network striving to develop vaccines to prevent HIV /trials will be conducted by the publicly funded, Hutch - based HIV Vaccine Trials Network, or HVTN, the largest global network striving to develop vaccines to prevent HIV /Trials Network, or HVTN, the largest global network striving to develop vaccines to prevent HIV / AIDS.

Since 1987, there have been over eighty trials of thirty different candidate AIDS vaccines.

On September 13, 2011, COL Jerome Kim, MHRP, and Dr. Bart Haynes, Duke University, presented two plenary sessions at the AIDS Vaccine conference on the discovery work related to correlates studies on the RV144 trial.

At the AIDS Vaccine conference in Bangkok on Tuesday, scientists announced an update to a Thai trial of a «modestly effective» experimental AIDS vVaccine conference in Bangkok on Tuesday, scientists announced an update to a Thai trial of a «modestly effective» experimental AIDS vaccinevaccine.

«After two years of analyzing the results of the largest AIDS vaccine clinical trial ever held — called RV144 — researchers say they have found two ways the immune system can respond, which could predict whether those inoculated will be protected or are more likely to become infected with HIV.»

The World Bank, the World Health Organization, and HIV groups everywhere rooted for VaxGen Inc of Brisbane, California, and it's «first Aids vaccine», which went into clinical trials in both the United States and Asia during the 1990s.

National Institute of Allergy and Infectious Diseases (NIAID) NIAID is the primary agency of the US government devoted to research on HIV / AIDS and the sponsor of the HIV Vaccine Trials Network.

At the first plenary session of AIDS Vaccine 2011, which opened this morning in Bangkok, Thailand, researchers presented the results of a two - year - long effort to try to identify an immunological explanation for the modest 31 % efficacy afforded by the prime - boost vaccine regimen tested in the RV144 trial, the first to show any efficacy in protecting against HIV infVaccine 2011, which opened this morning in Bangkok, Thailand, researchers presented the results of a two - year - long effort to try to identify an immunological explanation for the modest 31 % efficacy afforded by the prime - boost vaccine regimen tested in the RV144 trial, the first to show any efficacy in protecting against HIV infvaccine regimen tested in the RV144 trial, the first to show any efficacy in protecting against HIV infection.

Currently, there are twenty - two candidate AIDS vaccines undergoing human trials.

His researches led to the development of an AIDS vaccine, still in clinical trials.

At the International AIDS Society conference in Paris, scientists announced that in an early - stage clinical trial, a new HIV vaccine regimen generated antibody responses in 100 percent of volunteers in most arms of the study.

USAID's investments have been put to work by IAVI to enable both AIDS vaccine research and the cultivation of scientific and technical capacity at clinical research centers in developing countries that conduct vaccine trials in partnership with the organization.